8 thoughts on “25.08.21 Group 2”

  1. Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer

    Clare F. Malone, Neekesh V. Dharia, Guillaume Kugener, Alexandra B. Forman, Michael V. Rothberg, Mai Abdusamad, Alfredo Gonzalez, Miljan Kuljanin, Amanda L. Robichaud, Amy Saur Conway, Joshua M. Dempster, Brenton R. Paolella, Nancy Dumont, Volker Hovestadt, Joseph D. Mancias, Scott T. Younger, David E. Root, Todd R. Golub, Francisca Vazquez and Kimberly Stegmaier



  2. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

    Junyan Lu, Ester Cannizzaro, Fabienne Meier-Abt, Sebastian Scheinost, Peter-Martin Bruch, Holly A. R. Giles, Almut Lütge, Jennifer Hüllein, Lena Wagner, Brian Giacopelli, Ferran Nadeu, Julio Delgado, Elías Campo, Maurizio Mangolini, Ingo Ringshausen, Martin Böttcher, Dimitrios Mougiakakos, Andrea Jacobs, Bernd Bodenmiller, Sascha Dietrich, Christopher C. Oakes, Thorsten Zenz & Wolfgang Huber


    Liked by 1 person

  3. Article
    Open Access
    Published: 23 July 2021
    Human cell transformation by combined lineage conversion and oncogene expression
    Biswajyoti Sahu, Päivi Pihlajamaa, Kaiyang Zhang, Kimmo Palin, Saija Ahonen, Alejandra Cervera, Ari Ristimäki, Lauri A. Aaltonen, Sampsa Hautaniemi & Jussi Taipale
    Oncogene (2021)Cite this article



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s